All India Institute of Medical Sciences (AIIMS) in the country’s capital is starting the trial of Covaxin on children from Monday. This vaccine has been made by Bharat Biotech. DCGI had given its approval on May 11 for this clinical trial to be done on these children of Covaxin. 18 children will be included in the first phase of the trial. The target has been set to complete this entire test in eight weeks. In this, the effect of the vaccine on children and the body’s immunity will be studied. targeted to be completed.
Let us tell you that the clinical trial of this vaccine in AIIMS Patna has started from June 3 on children aged 2 to 18 years. Under this, complete screening of children is being done. It was given to him only after he became completely healthy.
Also Read DELHI: ORDER REVOKING NURSES’ BAN ON SPEAKING MALAYALAM’
Significantly, experts are constantly saying that the third wave of the corona epidemic may come in India. Experts also fear that children may be most affected by the virus in this wave. In such a situation, clinical trials on children are being seen as a shield. Apart from Delhi, Patna, Nagpur-based Meditrina Institute of Medical Science has also been selected for a clinical trial of this vaccine on children. Talking about Patna itself, this trial of Covaxin is being done on children between the age group of 12 to 18 years. After this, it will be done on children of 6-12 years and then 2-6 years.
Let us tell you that while many countries have approved giving vaccine doses to children of different age groups, the World Health Organization says that giving vaccines to children is not included in its priority. The organization says that only those who need the vaccine first should be given it.
